Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora” pursuant to Article 14 of Regulation (EC) No 1924/2006
Abstract Following an application from CSL ‐ Centro Sperimentale del Latte S.p.A., submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substant...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-07-01
|
| Series: | EFSA Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.2903/j.efsa.2011.2288 |
| _version_ | 1818937280812810240 |
|---|---|
| author | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
| author_facet | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
| author_sort | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
| collection | DOAJ |
| description | Abstract Following an application from CSL ‐ Centro Sperimentale del Latte S.p.A., submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora”. The scope of the application was proposed to fall under a health claim referring to children's development and health. The food constituent that is the subject of the health claim, a combination of L. delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and S. thermophilus 9Y/CSL (LMG P‐17225), has not been sufficiently characterised. The claimed effect is “beneficial modulation of the intestinal microflora”. The target population, as proposed by the applicant, is children from 3 months to 14 years old. No evidence has been provided by the applicant to establish that the claimed effect, “beneficial modulation of the intestinal microflora”, is a beneficial physiological effect. The Panel concludes that a cause and effect relationship has not been established between the consumption of the food constituent, the combination of L. delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and S. thermophilus 9Y/CSL (LMG P‐17225), and a beneficial physiological effect related to “beneficial modulation of the intestinal microflora”. |
| first_indexed | 2024-12-20T05:49:27Z |
| format | Article |
| id | doaj.art-f3d7f34a788b44bebcf0d1e43d02e31e |
| institution | Directory Open Access Journal |
| issn | 1831-4732 |
| language | English |
| last_indexed | 2024-12-20T05:49:27Z |
| publishDate | 2011-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | EFSA Journal |
| spelling | doaj.art-f3d7f34a788b44bebcf0d1e43d02e31e2022-12-21T19:51:14ZengWileyEFSA Journal1831-47322011-07-0197n/an/a10.2903/j.efsa.2011.2288Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora” pursuant to Article 14 of Regulation (EC) No 1924/2006EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)Abstract Following an application from CSL ‐ Centro Sperimentale del Latte S.p.A., submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora”. The scope of the application was proposed to fall under a health claim referring to children's development and health. The food constituent that is the subject of the health claim, a combination of L. delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and S. thermophilus 9Y/CSL (LMG P‐17225), has not been sufficiently characterised. The claimed effect is “beneficial modulation of the intestinal microflora”. The target population, as proposed by the applicant, is children from 3 months to 14 years old. No evidence has been provided by the applicant to establish that the claimed effect, “beneficial modulation of the intestinal microflora”, is a beneficial physiological effect. The Panel concludes that a cause and effect relationship has not been established between the consumption of the food constituent, the combination of L. delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and S. thermophilus 9Y/CSL (LMG P‐17225), and a beneficial physiological effect related to “beneficial modulation of the intestinal microflora”.https://doi.org/10.2903/j.efsa.2011.2288Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224)Streptococcus thermophilus 9Y/CSL (LMG P‐17225)intestinal “microflora”health claims |
| spellingShingle | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora” pursuant to Article 14 of Regulation (EC) No 1924/2006 EFSA Journal Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) Streptococcus thermophilus 9Y/CSL (LMG P‐17225) intestinal “microflora” health claims |
| title | Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora” pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_full | Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora” pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_fullStr | Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora” pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_full_unstemmed | Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora” pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_short | Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) and Streptococcus thermophilus 9Y/CSL (LMG P‐17225) and “beneficial modulation of intestinal microflora” pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| title_sort | scientific opinion on the substantiation of a health claim related to a combination of lactobacillus delbrueckii subsp bulgaricus ay csl lmg p 17224 and streptococcus thermophilus 9y csl lmg p 17225 and beneficial modulation of intestinal microflora pursuant to article 14 of regulation ec no 1924 2006 |
| topic | Lactobacillus delbrueckii subsp. bulgaricus AY/CSL (LMG P‐17224) Streptococcus thermophilus 9Y/CSL (LMG P‐17225) intestinal “microflora” health claims |
| url | https://doi.org/10.2903/j.efsa.2011.2288 |
| work_keys_str_mv | AT efsapanelondieteticproductsnutritionandallergiesnda scientificopiniononthesubstantiationofahealthclaimrelatedtoacombinationoflactobacillusdelbrueckiisubspbulgaricusaycsllmgp17224andstreptococcusthermophilus9ycsllmgp17225andbeneficialmodulationofintestinalmicroflorapursuanttoarticle14ofregulationecno1924200 |